Abstract: A display panel, a display device, and a method of manufacturing a display panel are provided. As an example, the display panel includes an array layer, a planarization layer, an inorganic layer, and at least one dam. The array layer includes a first region and a second region surrounding the first region. The planarization layer is at least partially located on a portion of the array layer which is at the first region. The inorganic layer is located on a portion of the array layer which is at the second region. The at least one dam is formed on the inorganic layer.

Abstract: A device may comprise security processing units (SPUs) including a SPU to receive a session request. The SPU may identify global counter information and update counter information. The global counter information may include a global counter identifier and a global counter value. The update counter information may include an update counter identifier and an update counter value. The SPU may identify a global limit associated with the global counter, may determine that the global limit has not been met, and may cause the session to be created. The SPU may create a modified global counter value. The SPU may create a modified update counter value. The SPU may determine that a local update message is required based on the modified update counter value, and may provide the local update message to another SPU. The local update message may include the global counter identifier and the modified global counter value.

Abstract: Spliceosome mutations are described herein, including mutations in the PHF5A and SF3B1 subunits. This application also describes detecting the presence and/or absence of mutations in the spliceosome, as well as methods of diagnosing responsiveness to splice modulator treatment, methods of treating neoplastic disorders, and methods of monitoring or altering the treatment based on mutation status.

Abstract: The present disclosure is related to non-alpha-substituted, low molecular weight peracid compositions. The peracids have no or a negligible amount of odor, have good stability, and have antimicrobial properties. The peracid compositions can be formulated into a wide variety of end use products, including disinfectants, sanitizers, sporicides, fungicides, laundry products, hard surface cleaners, bleaching agents, personal cleansers, and water treatment products.

Abstract: The present disclosure relates to a display panel and a display device. The display panel includes a display substrate and an encapsulating unit. The encapsulating unit is disposed on the display substrate, and the encapsulating unit includes at least one buffer layer. The buffer layer includes a buffer body and first buffer particles. The buffer body is deformable under an action of an external force thereby compressing the first buffer particles, and the first buffer particles are elastically deformable or capable of being crushed by compression.

Abstract: A system for reducing a resonant oscillation on a direct current bus is disclosed. The system includes a battery, a first capacitor connected in parallel with the battery, and an inductor connected in series with the first capacitor. The system also includes a first element connected in series with the inductor, a second element connected in parallel with the inductor and the first element, and a second capacitor connected in series with the first element. The system also includes an electric machine connected to the second capacitor. During a re-generation mode for charging the battery, a re-generation current o flows from the electric machine to the battery, passing through the first element and the inductor and bypassing the second element. Additionally, during a motor mode, a motor current flows from the battery to the electric machine, passing through the second element and bypassing the first element and the inductor.

Abstract: A disinfectant composition that is effective against tuberculosis-causing bacteria is disclosed. The composition contains a disinfectant agent that is a combination of biocidal quaternary ammonium compound and an N,N-di-substituted alkylamide water insoluble solvent. The composition can be a concentrated formulation or a ready-to-use formulation. Methods of disinfecting surfaces containing tuberculosis-causing bacteria are also disclosed.

Abstract: Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-? protein.

Abstract: A system for reducing a resonant oscillation on a direct current bus of a power inverter/converter for an electric machine having a variable frequency drive is disclosed. The system includes a battery, a first capacitor connected in parallel with the battery; an inductor connected in series with the first capacitor; a first diode connected in series with the inductor; a second diode connected in parallel with the inductor and the first diode; a second capacitor connected in series with the first diode; and a starter-generator connected to the second capacitor. During a re-generation mode for charging the battery, a re-generation current flows from the starter-generator to the battery, passing through the first diode and the inductor and bypassing the second diode. During a motor mode, a motor current flows from the battery to the starter-generator, passing through the second diode and bypassing the first diode and the inductor.

Abstract: The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.

Abstract: The present disclosure provides a humanized anti-BASIGIN antibody or antigen binding fragment thereof, which comprises heavy chain variable region (VH) comprising an amino acid sequence of SEQ ID NO: 1; optionally further comprise light chain variable region (VL) comprising an amino acid sequence of SEQ ID NO: 2. The present disclosure also provides a composition comprising the humanized anti-BASIGIN antibody or antigen binding fragment thereof, an isolated nucleic acid sequence encoding the humanized anti-BASIGIN antibody or antigen binding fragment thereof, a vector comprising the nucleic acid, a host cell comprising the vector, and use of the humanized anti-BASIGIN antibody or antigen binding fragment thereof.

Abstract: A liquid-repellent surface is provided where the repellency arises solely from the re-entrant surface structure. The liquid repellent surface is a porous membrane that contains hexagonally packed microcavities, each of which has a narrow opening located on its top. The surface is mechanically robust because the microstructures are interconnected in a continuous manner. A method of preparing the liquid repellent surface is also provided, which involves producing a uniform emulsion containing monodisperse micro-droplets, depositing the emulsion onto a substrate, and solidifying the emulsion-deposit by evaporating the solvent in the continuous phase fluid.

Abstract: A system and method includes obtaining, for a population of users of an online networking system having a common profession, data related to factors pertaining to the profession from a database of the online networking system and successively, for each of the factors individually, removing from the population of users those whose data relating to the factor is not similar to related data of a subject user until a quantity of the population of users is within a predetermined range to obtain a comparable population of users that have similar data to the subject user. A statistic is compared from the data of the subject user against the same statistic from the data of each of the users of the comparable population of users to obtain a comparison. The user interface displays the statistic and information related to the comparison.

Abstract: The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.

Abstract: The present disclosure is related to non-alpha-substituted, low molecular weight peracid compositions. The peracids have no or a negligible amount of odor, have good stability, and have antimicrobial properties. The peracid compositions can be formulated into a wide variety of end use products, including disinfectants, sanitizers, sporicides, fungicides, laundry products, hard surface cleaners, bleaching agents, personal cleansers, and water treatment products.

Abstract: A device includes a security process unit (SPU) associated with a logical ring of SPUs. The SPU receives a packet with an address associated with a malicious source, and creates, based on the packet, an entry in a data structure associated with the SPU. The entry includes information associated with the packet. The SPU provides an install message to a next SPU in the logical ring. The install message instructs the next SPU to create the entry in another data structure, and forward the install message to another SPU. The SPU receives the install message from a last SPU, and sets a state of the entry to active in the data structure based on receiving the install message from the last SPU. The SPU performs a particular action on another packet, associated with the malicious source, based on the setting the state of the entry to active.

Abstract: A device may comprise security processing units (SPUs) including a SPU to receive a session request. The SPU may identify global counter information and update counter information. The global counter information may include a global counter identifier and a global counter value. The update counter information may include an update counter identifier and an update counter value. The SPU may identify a global limit associated with the global counter, may determine that the global limit has not been met, and may cause the session to be created. The SPU may create a modified global counter value. The SPU may create a modified update counter value. The SPU may determine that a local update message is required based on the modified update counter value, and may provide the local update message to another SPU. The local update message may include the global counter identifier and the modified global counter value.

Abstract: Splice variants associated with neomorphic SF3B1 mutations are described herein. This application also relates to methods of detecting the described splice variants, and uses for diagnosing cancer, evaluating modulators of SF3B1, and methods of treating cancer associated with mutations in SF3B1.

Abstract: A system for reducing a resonant oscillation on a direct current bus of a power inverter/converter for an electric machine having a variable frequency drive is disclosed. The system includes a battery, a first capacitor connected in parallel with the battery; an inductor connected in series with the first capacitor; a first diode connected in series with the inductor; a second diode connected in parallel with the inductor and the first diode; a second capacitor connected in series with the first diode; and a starter-generator connected to the second capacitor. During a re-generation mode for charging the battery, a re-generation current flows from the starter-generator to the battery, passing through the first diode and the inductor and bypassing the second diode. During a motor mode, a motor current flows from the battery to the starter-generator, passing through the second diode and bypassing the first diode and the inductor.